Vertex Pharmaceuticals, Inc. (VRTX)
487.95
+6.94
(+1.44%)
USD |
NASDAQ |
Feb 24, 14:46
Vertex Pharmaceuticals Market Cap : 123.96B for Feb. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Moderna, Inc. | 19.94B |
| Gilead Sciences, Inc. | 183.60B |
| Eli Lilly & Co. | 988.27B |
| Merck & Co., Inc. | 308.69B |
| Pfizer Inc. | 154.22B |
Market Cap Related Metrics
| PE Ratio | 31.82 |
| PS Ratio | 10.43 |
| Price to Book Value | 6.641 |
| Price to Free Cash Flow | 39.42 |
| Price | 487.95 |
| Earnings Yield | 3.14% |
| Operating PE Ratio | 26.56 |
| Normalized PE Ratio | 29.09 |